Advertisement

Piperacillin Tazobactam Injection

[08 October 2014]

Products Affected - Description

Piperacillin/Tazobactam Injection, AuroMedics
3.375 gram vial, 10 count (NDC 55150-0120-30)
Piperacillin/Tazobactam Injection, Hospira
3.375 gram vial, 10 count (NDC 00409-3385-13)
3.375 gram ADD-Vantage vial, 10 count (NDC 00409-3378-13)
4.5 gram vial, 10 count (NDC 00409-3390-04)
 
Zosyn Injection, Pfizer
4.5 gram vial, 10 count (NDC 00206-8855-16)
40.5 gram bulk vial, 1 count (NDC 00206-8859-10)

Reason for the Shortage

  • Hospira has piperacillin/tazobactam on shortage due to manufacturing delays.
  • Pfizer has Zosyn on shortage due to manufacturing delays.
  • WG Critical Care states the reason for the shortage was increased demand.

Available Products

Piperacillin/Tazobactam Injection, Apotex
2.25 gram vial, 10 count (NDC 60505-0686-04)
3.375 gram vial, 10 count (NDC 60505-0687-04)
4.5 gram vial, 10 count (NDC 60505-0688-04)
40.5 gram bulk vial, 1 count (NDC 60505-0773-00)

Piperacillin/Tazobactam Injection, AuroMedics
2.25 gram vial, 10 count (NDC 55150-0119-30)
4.5 gram vial, 10 count (NDC 55150-0121-50)

Piperacillin/Tazobactam Injection, Fresenius Kabi
2.25 gram vial, 10 count (NDC 63323-0309-20)
3.375 gram vial, 10 count (NDC 63323-0300-30)
4.5 gram vial, 10 count (NDC 63323-0320-50)
40.5 gram bulk vial, 1 count (NDC 63323-0304-74)

Piperacillin/Tazobactam Injection, Hospira
2.25 gram ADD-Vantage vial, 10 count, NDC 00409-3374-02)
2.25 gram vial, 10 count (NDC 00409-3383-02)
4.5 gram ADD-Vantage vial, 10 count (NDC 00409-3379-04)

Piperacillin/Tazobactam Injection, Sagent
2.25 gram vial, 10 count (NDC 25021-0164-30)
3.375 gram vial, 10 count (NDC 25021-0165-30)
4.5 gram vial, 10 count (NDC 25021-0166-48)
 
Piperacillin/Tazobactam Injection, Sandoz
2.25 gram vial, 10 count (NDC 00781-3110-95)
3.375 gram vial, 10 count (NDC 00781-3113-95)
4.5 gram vial, 10 count (NDC 00781-3114-95)

Piperacillin/Tazobactam Injection, WG Critical Care
2.25 gram vial, 10 count (NDC 44567-0801-10)
3.375 gram vial, 10 count (NDC 44567-0802-10)
4.5 gram vial, 10 count (NDC 44567-0803-10)
40.5 gram bulk vial, 1 count (NDC 44567-0804-01)

Zosyn, Baxter
2.25 gram/50 mL frozen premix bag (NDC 00206-8860-01)
3.375 gram/50 mL frozen premix bag (NDC 00206-8861-01)
4.5 gram/50 mL frozen premix bag (NDC 00206-8862-01)
 
Zosyn Injection, Pfizer
2.25 gram vial, 10 count (NDC 00206-8852-16)
3.375 gram vial, 10 count, NDC 00206-8854-16

Estimated Resupply Dates

  • Auromedics has piperacillin tazobactam 3.375 gram vials on back order and the company estimates a release date in mid-October 2014.
  • Hospira has piperacillin tazobactam 3.375 gram vials, 3.375 gram ADD-vantage vials, and 4.5 gram vials on back order and the company estimates a release date in October 2014.
  • Pfizer has Zosyn 4.5 gram vials on back order and the company estimates a release date in late-October 2014. Zosyn 40.5 gram vials are on allocation.

Related Shortages

Updated

October 8, 2014; September 22, 2014; September 3, 2014; August 19, 2014; August 7, 2014; August 6, 2014; July 17, 2014; July 2, 2014; June 2, 2014; May 14, 2014; May 5, 2014; April 23, 2014; March 31, 2014; March 28, 2014; March 12, 2014; March 5, 2014; February 5, 2014, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement